Glucose sensor

By employing glucose dehydrogenase with defined Michaelis constants for D-glucose and D-xylose, the method addresses the interference issue in glucose sensors, providing accurate glucose monitoring.

DE202018006944U1Active Publication Date: 2024-11-07TOYOBO CO LTD
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
DE202018006944
Authority / Receiving Office
DE · DE
Patent Type
Utility models
Current Assignee / Owner
Priority Date
2018-02-02
Filing Date
2018-06-22
Publication Date
2024-11-07
Estimated Expiration
2028-06-30

AI Technical Summary

Technical Problem

Existing glucose monitoring methods using flavin-binding glucose dehydrogenase (FADGDH) are affected by D-xylose, leading to inaccurate blood glucose readings due to the lack of clear physicochemical properties reflecting the practical influence of D-xylose on glucose sensors.

Method used

The use of glucose dehydrogenase with specific Michaelis constants (Km) for D-glucose of 0.1 to 100 mM and D-xylose of 736 to 3000 mM, ensuring minimal interference from D-xylose, thereby enhancing the accuracy of glucose measurements.

Benefits of technology

This approach allows for accurate glucose monitoring by minimizing the impact of D-xylose, ensuring reliable blood glucose level measurements in glucose sensors.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

A glucose sensor comprising a glucose dehydrogenase on a carbon electrode or a metal electrode, wherein the glucose dehydrogenase has the following properties (1) and (2): (1) a Km for D-glucose of 0.1 mM or more and 100 mM or less; and (2) a Km for D-Xylose of 736 mM or more and 3000 mM or less.
Need to check novelty before this filing date? Find Prior Art

Description

Technical area

[0001] The present invention relates to a glucose monitoring method and a glucose sensor. background

[0002] Self-monitoring of blood glucose (SMBG) is important for diabetes patients to measure, manage, and control their blood glucose levels daily, thus supporting treatment. In recent years, simple self-monitoring devices using an electrochemical biosensor have become widely available for SMBG. A typical biosensor of this type, for example, is a device in which electrodes and an enzyme-reactive layer are formed on an insulating substrate.

[0003] Known glucose-monitoring enzymes used in biosensors include glucose dehydrogenase (hereinafter referred to as "GDH") and glucose oxidase (hereinafter referred to as "GO") (EC 1.1.3.4). Depending on the difference in the required coenzyme, GDH is further subdivided into pyrroloquinoline quinone-dependent glucose dehydrogenase (hereinafter referred to as "PQQGDH") (EC 1.1.5.2 (formerly EC 1.1.99.17)) and flavin-binding glucose dehydrogenase (e.g., flavin adenine dinucleotide-dependent glucose dehydrogenase (hereinafter referred to as "FADGDH") (EC 1.1.99.10)).

[0004] It has been pointed out that a glucose monitoring method using GO is easily affected by dissolved oxygen in the measurement sample, and dissolved oxygen affects the measurement results. In contrast, it has been pointed out that a method using PQQGDH is not affected by dissolved oxygen but is sensitive to sugars other than glucose, such as maltose and lactose. Furthermore, a method using FADGDH is known to be unaffected by dissolved oxygen and is barely sensitive to maltose or lactose.

[0005] Along with maltose and lactose, D-xylose is also considered a sugar that can cause problems for diabetic patients when measuring their blood sugar levels. At a medical site, D-xylose is used for xylose absorption to assess the ability of carbohydrates to be absorbed from the small intestine. Therefore, if a diabetic patient's blood sugar level is measured using glucose dehydrogenase with D-xylose activity, the accuracy of the readings may be compromised.

[0006] Specifically, regarding methods for assessing the influence of impurities in SMBG sensors, the US FDA published NPL 1. Regarding the influence of D-xylose, NPL 1 recommends that a response value be measured in a solution in which a glucose solution is spiked with D-xylose at a concentration of 200 mg / dL, and that the response value be reported with a 95% confidence interval relative to a response value obtained under non-spiked conditions.

[0007] Accordingly, D-xylose activity on SMBG sensors is often evaluated using the spike test. To reliably ensure that there is no influence of D-xylose, the performance evaluation can be performed by setting the D-xylose concentration used in the spike test higher than the concentration described in NPL 1.

[0008] The practical D-xylose activity in SMBG sensors is often evaluated using the spike test, as in NPL 1, while the D-xylose activity of FADGDH used in SMBG sensors is currently often discussed primarily in relation to the D-xylose activity in aqueous systems. For example, PTL 1 states that the amount of D-glucose can be accurately measured using FADGDH with a D-xylose activity of 2% or less when the D-glucose activity is 100%. Citation listPatent literature

[0009] PTL 1: JP4648993B Non-patented literature

[0010] NPL 1: Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use: Guidance for Industry and Food and Drug Administration Staff, published October 11, 2016 (http: / / www.raps.org / Regulatory-Focus / News / 2016 / 10 / 07 / 25966 / FDA-Finalizes-Two-Guidance-Documents-on-Blood-Glucose-Monitoring-Systems / ) Summary of the inventionTechnical problem

[0011] As described above, the evaluation of the D-xylose activity of FADGDH used in SMBG sensors has been discussed mainly in terms of D-xylose activity in aqueous systems, and there are many reports of FADGDH allegedly exhibiting low D-xylose activity based on this evaluation method. However, there is the problem that FADGDH, which exhibits low activity for D-xylose in aqueous systems, is not necessarily unaffected by xylose in sensor systems. Regarding the question of whether the evaluation methods in aqueous systems truly reflect the activity for D-xylose in glucose sensors represented by SMBG sensors, no physicochemical properties of GDH have been reported to date, demonstrating that there is no practical influence of D-xylose on glucose sensors, apart from simply comparing the reactivity for each substrate.

[0012] An object of the present invention is to find physicochemical properties of GDH that reflect the absence of a practical influence of D-xylose on glucose sensors, which have not been clarified so far. More specifically, an object of the present invention is to provide a glucose sensor and a glucose monitoring method, wherein the method for evaluating GDH in an aqueous system is designed to reflect the activity of GDH on D-xylose on a glucose sensor to reduce its practical influence on D-xylose. Solution to the problem

[0013] As a result of extensive research considering the above-mentioned objectives, the inventors found that, as physicochemical properties sufficient for GDH to have no influence on D-xylose when applied to a glucose sensor, it is important that the Michaelis constant (hereinafter also referred to as "Km") of GDH for D-glucose be 100 mM or less, and that the Michaelis constant of GDH for D-xylose be 736 mM or more. The present inventors also found that a glucose sensor practically unaffected by D-xylose can be prepared by using GDH having the above-mentioned properties. Thus, the present invention is completed.

[0014] Specifically, the inventions presented below are provided. Item 1.

[0015] A glucose monitoring method using a glucose dehydrogenase comprising the following properties (1) and (2): (1) a Km for D-glucose of 0.1 mM or more and 100 mM or less; and (2) a Km for D-xylose of 736 mM or more and 3000 mM or less. Item 2.

[0016] The glucose monitoring method according to item 1, wherein the glucose dehydrogenase has a Km for D-xylose of 619 mM or more and 3000 mM or less. Item 3.

[0017] The glucose monitoring method according to item 1, wherein the glucose dehydrogenase has a Km for D-xylose of 736 mM or more and 3000 mM or less. Item 4.

[0018] The glucose monitoring method according to any one of items 1 to 3, wherein an enzyme electrode comprising glucose dehydrogenase is used. Item 5.

[0019] The glucose monitoring method according to any one of items 1 to 4, wherein the glucose dehydrogenase further has a D-xylose activity of 95% or more and 105% or less in an enzyme electrode method, wherein the D-xylose activity is a ratio (%) of a response value to a solution in which a 10 mM D-glucose solution is added with 20 mM D-xylose with respect to a response value to a 10 mM glucose solution Item 6.

[0020] A glucose sensor comprising a glucose dehydrogenase on a carbon electrode or a metal electrode, wherein the glucose dehydrogenase has the following properties (1) and (2): (1) a Km for D-glucose of 0.1 mM or more and 100 mM or less; and (2) a Km for D-xylose of 736 mM or more and 3000 mM or less. Item 7.

[0021] The glucose sensor according to item 6, wherein the glucose dehydrogenase further has a D-xylose activity of 95% or more and 105% or less in an enzyme electrode method, wherein the D-xylose activity is a ratio (%) of a response value to a solution in which a 10 mM D-glucose solution is added with 20 mM D-xylose with respect to a response value to a 10 mM glucose solution. Item 8.

[0022] The glucose sensor according to item 6 or 7, further comprising a mediator on the carbon or metal electrode. Element 9.

[0023] A method for producing a glucose sensor comprising measuring a Michaelis constant (Km) of a glucose dehydrogenase for xylose. Element 10.

[0024] The method for producing a glucose sensor according to item 10 further comprising measuring the Km of glucose dehydrogenase for xylose and selecting a glucose dehydrogenase having a Km of 600 nM or more. Advantageous effects of the invention

[0025] The present invention makes it possible to provide a glucose monitoring method and a glucose monitoring sensor both of which can accurately measure blood glucose levels without interference from D-xylose. Brief description of the drawings Fig. Figure 1: A graph showing the Michaelis constant (Km) for D-xylose from GDH1 to GDH4 and the D-xylose activity in an enzyme electrode method according to Example 1. Fig. 2: A graph showing the results of investigating the relationship between the reaction rate and the D-xylose concentrations of GDH-5 and GDH-6 in Example 2. Fig.3: A graph showing the relationship between the inverse of the reaction rate and the inverse of the D-xylose concentrations of GDH-5 and GDH-6 (Lineweaver-Burk plot) in Example 2. Fig. Figure 4: A graph showing the Michaelis constant (Km) for D-xylose from GDH1 to GDH6 and the D-xylose activity in an enzyme electrode method according to Example 2. Fig. 5: Schematic representation of an example of the principle of a method for measuring D-glucose using an enzyme electrode. Description of the embodiments

[0026] The present invention will be described in detail below.

[0027] One aspect of the present invention is a method for measuring D-glucose by an enzyme electrode method using glucose dehydrogenase having a Michaelis constant (Km) for D-xylose of 736 mM or more.

[0028] The glucose monitoring method of the present invention is characterized by the use of glucose dehydrogenase, which catalyzes the following reaction: D-glucose + electron acceptor (oxidized form) → D-glucono-δ-lactone + electron acceptor (reduced form)

[0029] The glucose dehydrogenase used in the present invention is not particularly limited, but is preferably flavin-binding glucose dehydrogenase. Flavin is a group of derivatives having a substituent at position 10 of dimethylisoalloxazine and is not particularly limited as long as it is an enzyme that uses a flavin molecular species as a coenzyme. Examples of flavin compounds include flavin adenine dinucleotide (FAD), flavin adenine mononucleotide (FMN), and the like; FAD is particularly preferred.

[0030] The glucose dehydrogenase used in the present invention is characterized by having a sufficiently high affinity for D-glucose and a sufficiently low affinity for D-xylose. Specifically, with respect to the affinity for D-glucose, Km for D-glucose is 100 mM or less, and with respect to the affinity for D-xylose, Km for D-xylose is 600 mM or more. The properties other than Km for D-glucose and Km for D-xylose are not particularly limited. For example, Km for D-glucose may be 100 mM or less, and preferably 90 mM or less. Since it is important that Km for D-glucose be low, the lower limit thereof is not particularly limited, but is above 0.1 mM, preferably 1 mM or more, more preferably 5 mM or more, and even more preferably 10 mM or more.Km for D-xylose may be 736 mM or more, preferably 619 mM or more, even more preferably 650 mM or more, 700 mM or more, 736 mM or more, 750 mM or more, or 819 mM or more, and particularly preferably 850 mM or more. Since it is important that Km for D-xylose be high, the upper limit thereof is not particularly limited; however, as estimated from the solubility of D-xylose, the upper limit of Km is preferably 3 M or less, more preferably 2.5 M or less, 2 M or less, or 1.5 M or less, and particularly preferably 1.3 M or less.

[0031] Other properties of the glucose dehydrogenase used in the present invention are not particularly limited. For example, the optimal temperature is preferably 35°C to 65°C, more preferably 40°C to 60°C, and even more preferably 45°C to 55°C.

[0032] Regarding temperature stability, the residual activity after 15 minutes of treatment at 50°C is preferably 70% or more, preferably 75% or more, and more preferably 80% or more.

[0033] The optimal pH is preferably between 5.0 and 8.5, more preferably between 5.5 and 8.0 and even more preferably between 6.0 and 7.5.

[0034] The pH stability is preferably 2.5 to 10.0, more preferably 3.5 to 9.0, and even more preferably 4.5 to 8.0 under treatment conditions at 25°C for 16 hours.

[0035] The sugar content is preferably 5% to 50%, more preferably 10% to 40% and even more preferably 20% to 30%.

[0036] In particular, the preferred glucose dehydrogenase has the following properties as basic properties in addition to the Km for D-xylose. Optimal temperature: 50 to 55°C Temperature stability: The residual activity after 15 minutes of treatment at 50 °C is 80% or more. Optimal pH value: about 7.0 pH stability: 4.0 to 8.0 (25 °C, 16 hours) Sugar content: 20 to 50% Km for D-glucose: 50 to 70 mM

[0037] Alternatively, glucose dehydrogenase with the following properties can be used. Optimal temperature: 50 to 70°C Temperature stability: The residual activity after 15 minutes of treatment at 50 °C is 80% or more. Optimal pH value: 6.5 to 7.5 pH stability: 2.5 to 10.0 (25°C, 16 hours) Sugar content: 10 to 40% Km for D-glucose: 10 to 90 mM

[0038] Alternatively, a glucose dehydrogenase with the following properties can be used. Optimal temperature: 45 to 50°C Temperature stability: The residual activity after 15 minutes of treatment at 45 °C is 80% or more. Optimal pH value: 6.0 to 6.5 pH stability: 3.5 to 6.5 (25 °C, 16 hours) Sugar content: 20 to 50% Km for D-glucose: 5 to 20 mM

[0039] The origin of the glucose dehydrogenase used in the present invention is not particularly limited. Examples include fungi, such as the genera Penicillium, Aspergillus, and Talaromyces, and microorganisms belonging to the Mucoraceae family, such as the genera Mucor, Absidia, and Actinomucor.

[0040] Examples of the genus Penicillium include species such as Penicillium italicum and Penicillium lilacinoechinulatum. Examples of the genus Aspergillus include species such as Aspergillus oryzae, Aspergillus terreus, Aspergillus niger, and Aspergillus flavus. Other examples of microorganisms belonging to the Mucoraceae include the genera Mucor, Actinomucor, Rhizoh Mucor, Circinella, Parasitella, Zygorhynchus, Dicranophora, Spinellus, Sporodiniella, Rhyzopus, Absidia, Chlamidoabsidia, and Thermomucor. Examples of the genus Mucor include species such as Mucor guilliermondii, Mucor prainii, Mucor javanicus, Mucor hiemalis, and Mucor circinelloides.

[0041] The glucose dehydrogenase used in the present invention can be obtained by extraction and purification from a natural source. If information such as the amino acid sequence and the gene sequence encoding the amino acid sequence is already known (e.g., the amino acid sequence of SEQ ID NO: 5), the glucose dehydrogenase can be produced by genetic engineering based on this information. The glucose dehydrogenase used in the present invention may be a naturally occurring enzyme or a product obtained by altering or chemically modifying the amino acid sequence of a naturally occurring enzyme by a known genetic engineering method (hereinafter also referred to as a "variant").

[0042] As long as it is a glucose dehydrogenase having a Michaelis constant for D-xylose of 736 mM or more, preferred examples of the variant include glucose dehydrogenase having 70% or more (preferably 80% or more, more preferably 90% or more, even more preferably 95% or more, even more preferably 98% or more, and still more preferably 99% or more) identity with the amino acid sequence represented by SEQ ID NO: 5. As long as it is glucose dehydrogenase having a Michaelis constant for D-xylose of 619 mM or more, a preferred example of the variant may be one comprising an amino acid sequence having substitution, deletion, insertion, and / or addition of one or more amino acid residues in the amino acid sequence represented by SEQ ID NO: 5.

[0043] One aspect of the glucose monitoring method of the present invention has the following property (I) and / or (II). (I) D-glucose is measured by an enzyme electrode method using glucose dehydrogenase with a Michaelis constant (Km) for D-xylose of 619 mM or more. (II) The D-xylose activity (ratio (%) of a response value to a solution in which a 10 mM D-glucose solution is added with 20 mM D-xylose with respect to a response value to a 10 mM D-glucose solution) in an enzyme electrode method is 80% or more and 120% or less, preferably 85% or more and 115% or less, more preferably 90% or more and 110% or less, still more preferably 95% or more and 105% or less, and still further preferably 97% or more and 103% or less.

[0044] In contrast, it was found that the "D-xylose activity in an aqueous system," used as an evaluation criterion for substrate specificity in glucose measurement, did not correlate with the "D-xylose activity in the enzyme-electrode method." The reason for this result is believed to be that the D-xylose activity of FADGDH for D-glucose was expressed only by the activity at any substrate concentration in an aqueous system. For example, the D-xylose activity of FADGDH from Mucor prainii reported in PTL 1 was 1.4% when measured at 50 mM. However, according to the inventors' research, when the substrate concentration used for measurement was changed to 200 mM, the activity at 200 mM D-xylose in an aqueous system was 3.6%.This result shows that the “activity towards D-xylose in an aqueous system” is an index that depends on the concentration of the substrate to be measured.

[0045] The glucose sensor of the present invention is characterized by the use of glucose dehydrogenase having a Michaelis constant (Km) for D-xylose of 736 mM or more and 3000 mM or less and a Km for D-glucose of 0.1 mM or more and 100 mM or less.

[0046] The glucose sensor of the present invention is not particularly limited, and examples include the SMBG sensors described above. The glucose sensor may also be equipped with a computing unit for calculating a blood glucose level based on the signal intensity obtained from a reaction to glucose and a display for displaying the calculated blood glucose level. Furthermore, the glucose sensor of the present invention may be a sensor onto whose reactive layer blood or a diluted solution of blood as an analyte can fall dropwise, or the sensor may be equipped with a needle for piercing the skin of a subject to collect blood and / or a flow path for delivering blood; the needle and / or the flow path may be attachable.Alternatively, the sensor can be a CGM (continuous glucose monitoring) sensor, which can continuously monitor blood glucose levels, or an FGM (flash glucose monitoring) sensor.

[0047] In the present invention, the D-glucose concentration can be measured, for example, as follows. That is, a sample containing D-glucose is added to the reactive layer connected to the electrodes of the glucose sensor to trigger a reaction, followed by applying a constant voltage to the electrodes. The current is monitored, and the current accumulated during a predetermined period from the start of voltage application is summed, or the current value is measured after a predetermined period has elapsed from the start of voltage application. The D-glucose concentration of the sample can be calculated from the value based on a calibration curve prepared from a D-glucose solution of standard concentration. 1. Method for measuring glucose dehydrogenase activity

[0048] In the present invention, the activity of glucose dehydrogenase is defined by taking as 1 unit (U) the amount of enzyme that reduces 1 micromole of DCPIP per minute in the presence of a substrate according to a method using a reagent having the following formulation. - Reagent 50 mM PIPES buffer (pH: 6.5; with 0.1% TritonX-100) 24 mM PMS solution 2 mM 2,6-dichlorophenolindophenol (DCPIP) solution 1 M D-glucose solution

[0049] The above solutions are mixed to prepare a reaction reagent containing 200 mM D-glucose, 0.068 mM DCPIP, 1.63 mM PMS, 0.1% Triton X-100, and 35 mM PIPES buffer (pH 6.5). - Measurement conditions

[0050] First, 3 ml of the reaction reagent is preheated at 37 °C for 5 minutes. 0.1 ml of GDH solution is added, and the mixture is gently mixed. Then, the change in absorbance at 600 nm is recorded for 5 minutes using a spectrophotometer set at 37 °C, using water as a control, and the change in absorbance per minute (ΔOD TEST ) is measured using the straight line segment. In a blind test, a solvent that dissolves GDH is added to the reagent mixture instead of the GDH solution, and the change in absorbance per minute (ΔOD BLANK ) is also measured. From these values, GDH activity is determined using the following formula. One unit (U) of GDH activity is defined as the amount of enzyme that reduces 1 micromole of DCPIP per minute in the presence of D-glucose at a concentration of 200 mM. Activity(U / ml)={−(ΔODTEST−ΔODBLANK)×3.0×dilution magnification}{16.3×0.1×1.0}

[0051] In the formula, 3.0 represents the volume (ml) of the reaction reagent and the enzyme solution, 16.3 represents the millimolar molecular extinction coefficient (cm 2 / micromol) under the conditions for this activity measurement, 0.1 for the volume (ml) of the enzyme solution and 1.0 for the optical path length (cm) of the cell. 2. Michaelis constant for D-glucose of glucose dehydrogenase

[0052] The Michaelis constant (Km) for D-glucose of glucose dehydrogenase is calculated in the present invention from the Lineweaver-Burk plot. It can be calculated, in particular, by measuring the reaction rate at four D-glucose concentrations (30 mM, 50 mM, 100 mM, and 200 mM) using the method for measuring D-glucose dehydrogenase activity described above under 1. 3. Method for determining the D-xylose activity of glucose dehydrogenase in an aqueous system

[0053] The D-xylose activity of glucose dehydrogenase in an aqueous system is evaluated as follows. In the method for measuring glucose dehydrogenase activity described in section 1, the reactivity for glucose and the reactivity for D-xylose are determined using two methods with two substrate concentrations of 50 mM and 200 mM, and the ratio of the reactivity for xylose to the reactivity for glucose is calculated for evaluation. The reactivity for xylose is determined under the following measurement conditions. - Reagent 50 mM PIPES buffer (pH: 6.5; with 0.1% TritonX-100) 24 mM PMS solution 2 mM 2,6-dichlorophenolindophenol (DCPIP) solution 1 M D-xylose solution

[0054] The above solutions are mixed to prepare a reaction reagent containing 50 mM or 200 mM D-xylose, 0.068 mM DCPIP, 1.63 mM PMS, 0.1% Triton X-100, and 35 mM PIPES buffer (pH: 6.5). - Measurement conditions

[0055] First, 3 ml of the reaction reagent is preheated at 37 °C for 5 minutes. 0.1 ml of GDH solution is added, and the mixture is gently mixed. Then, the change in absorbance at 600 nm is recorded for 5 minutes using a spectrophotometer set to 37 °C, using water as a control, and the change in absorbance per minute (ΔOD TEST ) is measured using the straight line segment. In a blind test, a solvent that dissolves GDH is added to the reagent mixture instead of the GDH solution, and the change in absorbance per minute (ΔOD BLANK ) is measured in a similar manner. From these values, the reactivity for xylose is determined using the method described under 1. 4. Michaelis constant for D-xylose of glucose dehydrogenase

[0056] The Michaelis constant (Km) for D-xylose of glucose dehydrogenase is calculated from the Lineweaver-Burk plot in the present invention. Specifically, it can be calculated by changing the substrate from D-glucose to D-xylose in the method for measuring glucose dehydrogenase activity described in Figure 1 and measuring the reaction rate at different D-xylose concentrations. The D-xylose concentration used for the calculation can be adjusted to an appropriate concentration according to the Michaelis constant of the enzyme. However, in the present invention, when Km is between 0 mM and 100 mM, four points are plotted: 30 mM, 50 mM, 100 mM, and 200 mM. If Km is between 100 mM and 500 mM, 4 points are plotted: 50 mM, 200 mM, 600 mM, and 1000 mM; and if Km is between 500 mM and 1500 mM, 4 points are plotted: 50 mM, 200 mM, 600 mM, and 1400 mM. 5. Enzyme electrode method

[0057] The enzyme electrode method used in the present invention is not particularly limited. Fig. Figure 5 shows an example of the principle of a method for measuring D-glucose using an enzyme electrode. Glucose dehydrogenase catalyzes a reaction in which the hydroxyl group of glucose is oxidized to produce glucono-δ-lactone in the presence of a mediator (electron acceptor). When FADGDH acts on D-glucose, the coenzyme FAD becomes FADH2 (reduced form); however, when an iron(III) cyanide (e.g., "Fe(CN)6") 3- ) is present as a mediator, FADH2 (reduced form) converts it into a ferrocyanide (in this case "Fe(CN)6" 4-) and itself reverts to FAD (oxidized form). When an electrical voltage is applied, the ferrocyanide donates an electron to the electrode and returns to ferricyanide. Therefore, an electrochemical signal can be detected by using such an electron-transfer substance as a mediator.

[0058] Although the electrochemical measurement method used for the electrode is not particularly limited, various electrochemical measurement methods can be applied using a general potentiostat or galvanostat. Specific measurement methods include amperometry, potentiometry, coulometry, and various other methods; however, a method that uses amperometry to measure a current value generated upon application of a reduced mediator during oxidation is particularly preferred. The applied voltage in this case is preferably 10 to 700 mV, more preferably 50 to 500 mV, and even more preferably 100 to 400 mV.

[0059] The measurement system can be a two-electrode system or a three-electrode system. The working electrode can be a carbon electrode or a metal electrode such as platinum, gold, silver, nickel, or palladium. In the case of a carbon electrode, pyrolytic graphite, glassy carbon (GC), carbon paste, plastically formed carbon (PFC), or the like can be used. In the case of a metal electrode, gold is particularly preferred. Generally, the glucose dehydrogenase is located on the working electrode. Examples of the method for immobilizing the enzyme on the electrode include a method using a cross-linking reagent, a method in which the enzyme is encapsulated in a polymer matrix, a method in which the enzyme is coated with a dialysis membrane, and a method using a photocross-linkable polymer, a conductive polymer, and a redox polymer.The enzyme can be supported on a support via a functional group and a spacer connecting the functional group and the support. Alternatively, the enzyme can be immobilized in a polymer or adsorbed onto the electrode along with a mediator such as ferricyanide, ferrocene, or a derivative thereof, or a combination thereof. An example of the method is the immobilization of FADGDH on a carbon electrode using glutaraldehyde and subsequent treatment with an amino group-containing reagent to block glutaraldehyde. The reference electrode is not particularly limited, and electrodes commonly used in electrochemical experiments can be used. Examples include a saturated calomel electrode and a silver-silver chloride electrode.

[0060] For example, glucose concentration can be measured as follows. First, a buffer is added to a constant-temperature cell and maintained at a constant temperature. Potassium ferricyanide, phenazine methosulfate, or similar mediators can be used. An electrode immobilized with FADGDH serves as the working electrode, and a counter electrode (e.g., a platinum electrode) and a reference electrode (e.g., a Ag / AgCl electrode) are used. A constant voltage is applied to the carbon electrode, and after the current becomes uniform, a sample containing D-glucose is added, and the current increase is measured. The glucose concentration of the sample can be calculated from a calibration curve prepared from a D-glucose solution of standard concentration.

[0061] Printed electrodes can be used to reduce the amount of solution required for measurement and facilitate small-scale measurement. In this case, the electrodes are preferably formed on an insulating substrate. In particular, the printed electrodes are preferably applied to the substrate by a photolithographic process or a printing process such as screen printing, gravure printing, or flexographic printing. Examples of the material of the insulating substrate include silicon, glass, ceramic, polyvinyl chloride, polyethylene, polypropylene, polyester, and the like. Preferably, a material that is highly resistant to various solvents and chemicals should be used.

[0062] The shape of the electrode is not particularly limited. Examples include a circular shape, an elliptical shape, and a rectangular shape; a circular shape is particularly preferable from the viewpoint of easy mounting of the enzyme solution to be immobilized. In the case of a circular shape, its radius is preferably 3 mm or less, more preferably 2.5 mm or less, and even more preferably 2 mm or less. The volume for applying the enzyme solution is preferably about 1 to 5 µL, and even more preferably about 2 to 3 µL. The immobilization reaction after applying the enzyme solution is preferably carried out under humid conditions.

[0063] The type of solution used for the enzyme reaction is not particularly limited. Examples include phosphate buffers such as PBS and good buffers such as TRIS, MOPS, PIPES, HEPES, MES, and TES. The pH of the buffer is preferably about 4.0 to 9.0, more preferably about 5.0 to 8.0, and even more preferably about 6.0 to 7.5. The concentration of the buffer is preferably about 1 to 200 mM, more preferably about 10 to 150 mM, and even more preferably about 20 to 100 mM. In addition, various organic acids, salts, preservatives, and the like can be used as additives if necessary.

[0064] The embodiment of the glucose sensor of the present invention is not particularly limited. For example, a glucose sensor that can mount a chip containing GDH and an electron carrier on an electrode is preferable. The reactive layer formed on the electrode can contain, in addition to GDH and the electron carrier, a reaction accelerator, a thickener, a stabilizer, a pH buffer, and other components.

[0065] A mediator can be used to mediate the enzyme reaction and electron transfer between the electrodes. The type of mediator that can be used is not particularly limited; however, examples include quinones, cytochromes, viogens, phenazines, phenoxazines, phenothiazines, ferricyanides, ferredoxins, ferrocenes, and derivatives thereof. More specific examples include benzoquinone / hydroquinone, ferricyanide / ferrocyanide (potassium or sodium salts), and ferricinium / ferrocene. Phenazine methosulfate, 1-methoxy-5-methylphenazinium methylsulfate, 2,6-dichlorophenolindophenol, and the like can also be used. Metal complexes of, for example, osmium, cobalt, and ruthenium can also be used. If a compound with low water solubility is used as a mediator and an organic solvent, the stability of the enzyme may be lost or the enzyme activity may be inactivated.To increase water solubility, the mediator to be used can be a compound modified with a hydrophilic polymer such as polyethylene glycol (PEG). The concentration of the mediator in a reaction system is preferably about 1 mM to 1 M, more preferably 5 to 500 mM, and even more preferably 10 to 300 mM. The mediator can also be used by immobilizing it together with the enzyme on the electrode, for example, by using modified products with various functional groups.

[0066] The reaction accelerator is not particularly limited; examples include polyglutamic acid.

[0067] The thickener is not particularly limited, as long as it is a substance that can ensure the required viscosity to adhere the coated composition to the reactive layer of the glucose sensor. Preferred examples include pullulan, dextran, polyethylene glycol, poly-γ-glutamic acid, carboxymethylcellulose, polyvinylpyrrolidone, and clay. Examples of clay include those with a kaolinite or pyrophyllite structure, such as pyrophyllite, mica, smectite, vermiculite, chlorite, kaolinite, and halloysite. Among these, smectite is a preferred example of a thickener. Smectite is further subdivided into montmorillonite, beidellite, nontronite, saponite, hectorite, and the like. Smectite can be synthetic smectite. For example, commercial products such as the "Lucentite" series (manufactured by Coop Chemical Co., Ltd.) are available.

[0068] The amount of the thickener added to the composition is not particularly limited as long as the effect of improving the stability of the composition is recognized. The concentration of the thickener in a liquid composition is preferably 0.01% or more and 5% or less, and more preferably 0.1% or more and 1% or less. Further, in a solid composition obtained by heating, freeze-drying, or the like, the amount of the thickener added is preferably 0.5% or more and 70% or less, and more preferably 4.5% or more and 30% or less.

[0069] The stabilizer is not particularly limited, and examples include substances such as glycylglycine, sorbitol, and adonitol. The added amount is not particularly limited as long as the effect of improving the stability of the composition is recognized. The concentration thereof in a liquid composition is preferably 0.1% or more and 10% or less, and more preferably 0.2% or more and 2% or less. In a solid composition obtained by heating, freeze-drying, or the like, the amount of the stabilizer added is preferably 1% or more and 80% or less, and more preferably 2% or more and 50% or less.

[0070] When combining a stabilizer and a thickener, the combination is not particularly limited, but preferably glycylglycine and carboxymethylcellulose, glycylglycine and smectite, glycylglycine and polyvinylpyrrolidone, sorbitol and carboxymethylcellulose, sorbitol and smectite, sorbitol and polyvinylpyrrolidone, adonitol and carboxymethylcellulose, adonitol and smectite, or adonitol and polyvinylpyrrolidone. Among these combinations, glycylglycine and smectite, sorbitol and smectite, or adonitol and smectite are most suitable.

[0071] Although other ingredients are not particularly limited, a surfactant, for example, may be used. When a surfactant is used, examples include Triton X-100, Tween 20, sodium deoxycholate, Emulgen 430, and the like.

[0072] The composition of the reactive layer can be liquid or dried to solidify. Examples of the solidification method include, but are not limited to, a method of evaporating water by heating, a method of drying in air at room temperature or higher, a method of evaporating water by applying a vacuum, and a method of removing water by applying a vacuum in a frozen state.

[0073] In the enzyme reaction, in a state where the desired amounts of enzyme and mediator are added and mixed in a desired volume of the reaction solution, a predetermined amount of a substrate-containing sample solution, such as blood, is added, and the measurement is started simultaneously. Although the electrochemical detection method is not particularly limited, it is preferable to measure the current change that occurs during the transfer of electrons through the mediator when the enzyme reaction proceeds as a signal. The sample used for the measurement is not particularly limited and can be a biological sample such as blood, body fluid, or urine, as well as an aqueous solution that contains or may contain an enzyme substrate as a component. The measurement can be carried out at a reaction temperature that is as constant as possible. In addition, it is also possible to develop microanalysis using a microchannel device or the like. 6. Method for evaluating D-xylose activity using the enzyme electrode method

[0074] Xylose reactivity in the enzyme-electrode method is evaluated using a sensor chip prepared as follows and a solution in which 20 mM (equivalent to 300 mg / dL) D-xylose is added to a 10 mM glucose solution. This condition is set more stringent than the recommended condition of NPL 1, with reference to the condition described in NPL 1. - Manufacturing of the sensor chip

[0075] An electrode sensor comprising a working electrode, a counter electrode, and a reference electrode arranged on an insulating substrate was manufactured under contract by Biodevice Technology Co., Ltd. (Nomi City, Ishikawa Prefecture). In this electrode sensor, the electrodes are printed on the substrate (4.0 mm x 17 mm). 3 µL of an aqueous solution serving as a reagent layer is applied to the working electrode (area: approximately 1.3 mm). 2 ) of the sensor. The aqueous solution as a reagent layer has the following composition: 1000 U / ml FAD-GDH 200 mM potassium ferricyanide 50 mM potassium phosphate buffer (pH: 7.0)

[0076] This is dried by heating at 50 °C for 10 minutes to obtain a glucose sensor chip on which 3 U FADGDH per chip is immobilized. - Measurement conditions

[0077] A 10 mM glucose solution and a solution containing 10 mM glucose and 20 mM D-xylose are prepared. 5 µL of these sample solutions are dropped onto the chip connected to a potentiostat using a micropipette. 5 seconds after dropping, a voltage of +300 mV is applied, and the current is measured. The ratio (%) of a response value to the solution containing 10 mM glucose and 20 mM D-xylose relative to a response value to the 10 mM glucose solution is defined as the activity to xylose in the enzyme-electrode method. A value of 100% means there is no influence of D-xylose. The further this value is from 100%, the stronger the positive or negative influence of D-xylose.

[0078] The present invention will be described in more detail below with reference to examples; however, the present invention is not limited to these examples. ExamplesExample 1: Comparison of the properties of glucose dehydrogenase

[0079] Four types of FADGDH (GDH1 to GDH4, see below) were compared for their properties. The compared elements and the method for measuring each element are as follows. (a) D-xylose activity in an aqueous system at a substrate concentration of 50 mM Measurement method: The method described in “3. Method for the determination of D-xylose activity of glucose dehydrogenase in an aqueous system”. (b) Michaelis constant (Km) for D-xylose in an aqueous system. Measurement method: The method described under “4. Michaelis constant for D-xylose of glucose dehydrogenase”. (c) Michaelis constant (Km) for D-glucose in an aqueous system. Measurement method: The method described under “2. Michaelis constant for D-glucose of glucose dehydrogenase”. (d) D-xylose activity in an enzyme-electrode method Measurement method: The method described in “6. Method for evaluating D-xylose activity in an enzyme-electrode method”.

[0080] GDH-1 is obtained by genetically engineering and expressing the DNA sequence of SEQ ID No. 8 of JP527482B using the Cryptococcus sp. S-2 D11 strain (FERM BP-11482) described in JP5588578B (the amino acid sequence encoded by SEQ ID No. 8 of JP527482B is SEQ ID No. 1). GDH-2 is obtained by genetically engineering and expressing GDH with an amino acid sequence of SEQ ID No. 2 (the amino acid sequence represented by SEQ ID No. 1 of JP2013-116102A) using the Cryptococcus sp. S-2 D11 strain described in JP5588578B (FERM BP-11482).

[0081] GDH-3 is obtained by genetically engineering and expressing GDH with an amino acid sequence of SEQ ID No. 3 (the amino acid sequence represented by SEQ ID No. 1 of JP4649993B) using the Cryptococcus sp. S-2 D11 strain (FERM BP-11482) described in JP5588578B. GDH-4 is obtained by genetically engineering and expressing GDH with an amino acid sequence of SEQ ID No. 4 (the amino acid sequence represented by SEQ ID No. 1 of JP2015-146773A) using the Aspergillus oryzae NS4 strain (Transformation System for Aspergillus oryzae with Double Auxotropic Mutations, niaD and sC (Bioscience Biotechnology Biochemistry, 1997 Vol. 61, 1367-1369)).

[0082] Table 1 shows the results of the comparison of the different enzyme properties of GDH1 to GDH4. Table 1 GDH-1 GDH-2 GDH-3 GDH-4 (a) Xylose activity in 50 mM aqueous system (%) 11,3 1,1 1,4 2,9 (b) Michaelis constant for xylose (mM) 39 378 541 82 (c) Michaelis constant for glucose (mM) 68 16 31 14 d) Xylose activity in the enzyme electrode method (%, spike method) 190 122 121 180

[0083] The enzymes listed in Table 1 have a Km for D-glucose ranging from 14 to 82 mM, and their affinity for glucose is sufficiently high. First, the results of GDH-2 and GDH-3 are considered. These two GDH types had low D-xylose activity in an aqueous system. In particular, when xylose activity (a) was used as the evaluation standard in an aqueous system at a substrate concentration of 50 mM, their xylose activity was 2% or less, and these enzymes were evaluated as useful. However, when D-xylose activity (d) was used as the evaluation standard in an enzyme-electrode method, both GDH-2 and GDH-3 showed values ​​exceeding 120% in the spike method. This suggests that GDH-2 and GDH-3 have a great influence on D-xylose in glucose measurement with SMBG sensors.

[0084] Next, the results of GDH-1 and GDH-4 are considered. The D-xylose activity (a) of GDH-4 in the aqueous system is about 1 / 4 of the D-xylose activity (a) of GDH-1 in the aqueous system. If the D-xylose activity (a) in the aqueous system is a suitable index for evaluating the influence of GDH used on SMBG sensors on D-xylose, there should be a significant difference in the D-xylose activity (d) in the enzyme-electrode method between GDH-1 and GDH-4. However, the difference in the D-xylose activity (d) in the enzyme-electrode method between GDH-1 and GDH-4 is about 10%, and there is no effect consistent with the expectations derived from the difference in their D-xylose activity (a) in the aqueous system.

[0085] Here, attention is drawn to Km (b) for D-xylose from GDH-1 to GDH-4 and the D-xylose activity (d) in the enzyme-electrode method. From the comparison between Km (b) for D-xylose from GDH-1 to GDH-4 and the D-xylose activity (d) in the enzyme-electrode method ( Fig. 1) a correlation was expected between Km (b) for D-xylose and D-xylose activity (d) in the enzyme electrode method.

[0086] The D-xylose activity (d) in the enzyme-electrode method decreases as a function of the Km (b) for D-xylose. A regression line constructed from the Km (b) for D-xylose from GDH-1 to GDH-4 and the xylose activity (d) in the enzyme-electrode method suggests the possibility that the xylose activity (d) in the enzyme-electrode method is suppressed when the Km (b) for D-xylose is 619 mM or higher. Example 2: Preparation of GDH-5 and GDH-6 and comparison of properties

[0087] To test the above hypothesis derived from the results of Example 1, GDH with a Km (b) for D-xylose of 619 mM or more was screened. Example 1 of JP2015-84676A describes the construction of a random FADGDH mutant library using Saccharomyces yeast as the host. A random FADGDH mutant library was constructed using Saccharomyces yeast, comprising 1000 strains, as the host from DNA encoding GDH with the amino acid sequence of SEQ ID No. 5 by a method based on the method described in Example 1 of JP2015-84676A.

[0088] Specifically, random mutations were introduced into the FADGDH gene by error-prone PCR using pYESMh6754 (see JP2013-116102A) as a plasmid. On pYESMh6754, the GAL1 promoter and the CYC1 terminator are positioned with the FADGDH gene between them. Random mutations were introduced using the Diversify PCR Random Mutagenesis Kit (Clontech) according to the protocol included with the product, using primers capable of binding complementarily to the GAL1 promoter and CYC1 terminator. This yielded a DNA fragment containing the FADGDH gene, into which mutations were introduced at a specific ratio. Subsequently, the resulting DNA fragment containing the FADGDH gene with mutations introduced in a specific ratio was treated with the restriction enzymes KpnI and NotI and mixed with the vector pYES3 (Invitrogen), which had also been treated with the restriction enzymes KpnI and NotI.Then, a ligation reagent (Toyobo Ligation High) was added in an amount equal to the amount of the mixed liquid, followed by incubation, thereby performing ligation. The thus-ligated DNA was transformed into competent Escherichia coli DH5α cells (Competent high DH5α, manufactured by Toyobo Co., Ltd.) according to the protocol attached to the product to obtain a transformant. The transformant was cultured in LB medium, and the plasmid was extracted to obtain a random mutant plasmid library in which mutations were introduced at a constant ratio into the FADGDH gene inserted into the plasmid. The random mutant plasmid library was then transformed into Saccharomyces cerevisiae INVSc1 (Invitrogen). Approximately 2000 grown colonies were used as a random FADGDH mutant library with Saccharomyces as host.

[0089] The transformant contained in the library as described above was cultured according to a method based on the method described in Example 2 of JP2015-84676A. Specifically, the constructed FADGDH random mutant library using Saccharomyces as the host was inoculated into a medium containing 3% yeast extract, 1% polypeptone, and 3% galactose, which were added to each ScreenMates culture cell (Matrix Technology), and cultured with shaking at 25°C for 60 hours. Subsequently, the resulting culture solution was centrifuged at 2000 rpm for 15 minutes to obtain a culture supernatant.

[0090] By comparing the activity for D-xylose at concentrations of 200 mM and 600 mM in the culture supernatant, a modified GDH was selected that was expected to have low affinity for D-xylose. The selected modified GDH was purified, and the reaction rate for D-xylose at concentrations of 50 mM, 200 mM, 600 mM, and 1400 mM was confirmed, yielding GDH-5 with a Km (b) for D-xylose of 819 mM and GDH-6 with a Km (b) for D-xylose of 1271 mM. Fig. Figure 2 shows the results of the investigation of the ratio of the reaction rate of GDH-5 and GDH-6 for D-xylose at concentrations of 50 mM, 200 mM, 600 mM and 1400 mM, and Fig. Figure 3 shows the results of the Lineweaver-Burk plot, which is the basis for calculating the Michaelis constant (Km).

[0091] For GDH-5 with a Km (b) for D-xylose of 819 mM and GDH-6 with a Km (b) for D-xylose of 1271 mM, the D-xylose activity in an aqueous system at a substrate concentration of 200 mM, the D-xylose activity (a) in an aqueous system at a substrate concentration of 50 mM, and the D-xylose activity (c) were measured using an enzyme-electrode method and compared with GDH1 to GDH4. Table 2 shows the results. Table 2 GDH-1 GDH-2 GDH-3 GDH-4 GDH-5 GDH-6 (a) Xylose activity in 50 mM aqueous system (%) 11,3 1,1 1,4 2,9 0,9 0,5 (b) Michaelis constant for xylose (mM) 39 378 541 82 819 1271 (c) Michaelis constant for glucose (mM) 68 16 31 14 80 82 d) Xylose activity in the enzyme-electrode method (%, spike method) 190 122 121 180 100 101

[0092] As a result, GDH-5 with a Km (b) for D-xylose of 819 mM and GDH-6 with a Km (b) for D-xylose of 1271 mM had a D-xylose activity (c) of 100 to 101% in the enzyme electrode method, and it was confirmed that there was almost no effect on D-xylose. Fig. Figure 4 shows a comparison of Km (b) for D-xylose from GDH-1 to GDH-6 and D-xylose activity (c) in the enzyme electrode method.

[0093] From the Fig.From the results shown in Figure 4, it can be seen that in the range where Km (b) for D-xylose is less than about 736 mM, the D-xylose activity (d) in the enzyme-electrode method decreases with increasing Km (b) for D-xylose. In the range where Km (b) for D-xylose is about 736 mM or more, the D-xylose activity (d) in the enzyme-electrode method is almost not confirmed, and a state in which D-xylose does not affect glucose measurement is maintained.

[0094] Here, GDH-2 and GDH-5 are compared. In Table 2, GDH-2 and GDH-5 have a D-xylose activity (a) of approximately 1% in an aqueous system at a substrate concentration of 50 mM. Using this point as an evaluation criterion, both are treated as enzymes useful in terms of D-xylose activity. However, it was clarified that there is a significant difference in D-xylose activity (d) in the enzyme-electrode method between GDH-2 and GDH-5. GDH-2 has a D-xylose activity of 120% in the enzyme-electrode method, and there are concerns about the influence of D-xylose on glucose measurement by SMBG sensors. In contrast, GDH-5 has a D-xylose activity of 100% in the enzyme-electrode method, and GDH-5 has less influence on D-xylose in glucose measurement with SMBG sensors.

[0095] For example, it was shown that evaluating D-xylose activity in an aqueous system alone is insufficient, as the physicochemical characteristics for evaluating GDH used on SMBG sensors have no practical impact on D-xylose. Km(b) for D-xylose was found to be useful as an alternative index. According to the results of this example, if Km(b) for D-xylose is 619 mM or higher, it is considered that GDH has physicochemical properties sufficient to have little practical impact on D-xylose used on SMBG sensors.

[0096] The reason for the occurrence of this phenomenon is seen in the following points.

[0097] While the reaction rate of an enzyme in a solution is calculated by observation in minutes, in a sensor system formed by an enzyme-electrode method, changes in seconds or milliseconds are observed as current response values. From the results of Example 1, it was assumed that since the instantaneously measured current response value derived from D-xylose degradation was suppressed in the enzyme-electrode method using an enzyme with a low affinity for D-xylose, i.e., a sufficiently high Km, the variation in the current response values ​​under D-xylose spike conditions would be small.

[0098] The D-xylose activity of GDH1 to GDH6 in an aqueous system was also measured with a substrate concentration adjusted to 200 mM. The results were as follows: GDH-1: 9.9%, GDH-2: 4.9%, GDH-3: 3.6%, GDH-4: 4.6%, GDH-5: 1.8%, and GDH-6: 1.6%. Industrial applicability

[0099] The present invention makes it possible to provide a glucose monitoring method and a glucose monitoring sensor both capable of accurately measuring blood glucose, and which are expected to be widely used in the accurate control of blood glucose levels in the field of medical care for diabetes. QUOTES CONTAINED IN THE DESCRIPTION

[0000] This list of documents submitted by the applicant was generated automatically and is included solely for the convenience of the reader. This list is not part of the German patent or utility model application. The DPMA assumes no liability for any errors or omissions. Cited patent literature

[0000] JP4648993B

[0009] JP527482B

[0080] JP5588578B [0080, 0081] JP2013-116102A [0080, 0088] JP4649993B

[0081] JP2015-146773A

[0081] JP2015-84676A [0087, 0089] Zitierte Nicht-Patentliteratur

[0000] Self-Monitoring Blood Glucose Test Systems for Over-the-Counter Use: Guidance for Industry and Food and Drug Administration Staff, veröffentlicht am 11. Oktober 2016 (http: / / www.raps.org / Regulatory-Focus / News / 2016 / 10 / 07 / 25966 / FDA-Finalizes-Two-Guidance-Documents-on-Blood-Glucose-Monitoring-Systems

[0010] Transformation System for Aspergillus oryzae with Double Auxotorophic Mutations, niaD and sC (Bioscience Biotechnology Biochemistry, 1997 Vol. 61, 1367-1369

[0081]

Claims

[1] A glucose sensor comprising a glucose dehydrogenase on a carbon electrode or a metal electrode, wherein the glucose dehydrogenase has the following properties (1) and (2): (1) a Km for D-glucose of 0.1 mM or more and 100 mM or less; and (2) a Km for D-xylose of 736 mM or more and 3000 mM or less. [2] The glucose sensor according to claim 1, wherein the glucose dehydrogenase further has a D-xylose activity of 95% or more and 105% or less in an enzyme electrode method, wherein the D-xylose activity is a ratio (%) of a response value to a solution in which a 10 mM D-glucose solution is added with 20 mM D-xylose with respect to a response value to a 10 mM glucose solution. [3] The glucose sensor according to claim 1 or 2, further comprising a mediator on the carbon electrode or metal electrode. [4] Use of a glucose dehydrogenase in a reactive layer formed on the electrode of a glucose sensor, wherein the glucose dehydrogenase comprises the following properties (1) and (2): (1) a Km value for D-glucose of 0.1 mM or more and 100 mM or less; and (2) a Km for D-xylose of 736 mM or more and 3000 mM or less. [5] The use according to claim 4, wherein the glucose dehydrogenase further has a D-xylose activity of 95% or more and 105% or less in an enzyme electrode method, wherein the D-xylose activity is a ratio (%) of a response value to a solution in which a 10 mM D-glucose solution is added with 20 mM D-xylose with respect to a response value to a 10 mM glucose solution.

Citation Information

Patent Citations

  • Process for purifying maltose productive multienzyme

    JP1977007482A

  • New glucose dehydrogenase

    JP2013116102A

  • Flavine adenine dinucleotide dependent glucose dehydrogenase excellent in heat resistance

    JP2015084676A

  • Novel glucose dehydrogenase

    JP2015146773A

  • Flavin-bound glucose dehydrogenase

    JP4648993B2